Your browser doesn't support javascript.
loading
MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53.
Zhou, Xu; Wu, Weining; Zeng, Ailiang; Nie, Er; Jin, Xin; Yu, Tianfu; Zhi, Tongle; Jiang, Kuan; Wang, Yingyi; Zhang, Junxia; You, Yongping.
Afiliação
  • Zhou X; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Wu W; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Zeng A; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Nie E; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Jin X; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Yu T; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Zhi T; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Jiang K; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Wang Y; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • Zhang J; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
  • You Y; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, China.
Oncotarget ; 8(41): 71080-71094, 2017 Sep 19.
Article em En | MEDLINE | ID: mdl-29050344

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article